guhjy's Remuzzi:G [78 articles] Export

Recent papers posted to guhjy's library by the author Remuzzi:G. You can also see everyone's Remuzzi:G.

	Sirolimus to replace calcineurin inhibitors? Too early yet. [My Copy] Lancet, Vol. 373, No. 9671. (11 April 2009), pp. 1235-1236. by Paolo Cravedi, Piero Ruggenenti, Giuseppe Remuzzi posted to rt rapamycin csa 1 by guhjy on 2009-11-22 05:49:59 as
	Transplantation: time to rethink immunosuppression by mTOR inhibitors? [My Copy] Nature reviews. Nephrology, Vol. 5, No. 11. (November 2009), pp. 611-612. by Marcus D. Säemann, Giuseppe Remuzzi posted to rt rapamycin by guhjy on 2009-11-22 05:49:03 as
	Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. [My Copy] American journal of physiology. Renal physiology, Vol. 297, No. 5. (November 2009) by Elena Gagliardini, Daniela Corna, Carla Zoja, et al.Fabio Sangalli, Fabiola Carrara, Matteo Rossi, Sara Conti, Daniela Rottoli, Lorena Longaretti, Andrea Remuzzi, Giuseppe Remuzzi, Ariela Benigni posted to stz snx rat et dn acei by guhjy on 2009-11-15 07:11:52 as
	V1\|[sol]\|V2 Vasopressin receptor antagonism potentiates the renoprotection of renin\|[ndash]\|angiotensin system inhibition in rats with renal mass reduction [My Copy] Kidney International, Vol. 76, No. 9. (22 July 2009), pp. 960-967. by Norberto Perico, Carla Zoja, Daniela Corna, et al.Daniela Rottoli, Flavio Gaspari, Lloyd Haskell, Giuseppe Remuzzi posted to snx rat inhibitor arb adh acei by guhjy on 2009-11-15 03:58:37 as
	A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease. [My Copy] The New England journal of medicine (30 October 2009) by Marc A. Pfeffer, Emmanuel A. Burdmann, Chao-Yin Y. Chen, et al.Mark E. Cooper, Dick de Zeeuw, Kai-Uwe U. Eckardt, Jan M. Feyzi, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J. McMurray, Patrick Parfrey, Hans-Henrik H. Parving, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert Toto, the TREAT Investigators posted to rct outcome epo dm ckd by guhjy on 2009-11-09 14:02:21 as along with 1 person benjaminbertrand
	Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism. [My Copy] Pharmacogenetics and genomics, Vol. 19, No. 9. (September 2009), pp. 695-703. by Stefan Vegter, Annalisa Perna, Wâtse Hiddema, et al.Piero Ruggenenti, Giuseppe Remuzzi, Gerjan Navis, Maarten J. Postma posted to snp dn cea ace by guhjy on 2009-09-27 16:26:02 as
	The future of renoprotection. [My Copy] Kidney international. Supplement, No. 97. (August 2005) by Norberto Perico, Igor Codreanu, Arrigo Schieppati, Giuseppe Remuzzi posted to renoprotection by guhjy on 2009-09-22 16:32:16 as
	Hemolytic Uremic Syndrome [My Copy] J Am Soc Nephrol, Vol. 16, No. 4. (1 April 2005), pp. 1035-1050. by Marina Noris, Giuseppe Remuzzi posted to hus by guhjy on 2009-09-19 02:34:38 as
	Novel therapies of lupus nephritis. [My Copy] Current opinion in nephrology and hypertension, Vol. 17, No. 2. (March 2008), pp. 156-161. by Arrigo Schieppati, Giuseppe Remuzzi posted to lupus by guhjy on 2009-09-03 03:57:48 as
	Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. [My Copy] Cochrane database of systematic reviews (Online), No. 4. (2004) by A. Schieppati, A. Perna, J. Zamora, G. A. Giuliano, N. Braun, G. Remuzzi posted to mn meta-analysis by guhjy on 2009-08-30 02:15:38 as
	Treatment of chronic proteinuric kidney disease: what next? [My Copy] Hypertension, Vol. 54, No. 1. (July 2009), pp. 29-31. by Ariela Benigni, Giuseppe Remuzzi posted to ckd proteinuria by guhjy on 2009-08-08 03:29:56 as
	The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics. [My Copy] American journal of nephrology, Vol. 30, No. 3. (15 June 2009), pp. 280-286. by H. J. Lambers Heerspink, R. Agarwal, D. W. Coyne, et al.H-H H. Parving, E. Ritz, G. Remuzzi, P. Audhya, M. J. Amdahl, D. L. Andress, D. de Zeeuw posted to rct uae vdr vitamin-d by guhjy on 2009-07-06 00:51:32 as
	Proteinuria: Increased angiotensin-receptor blocking is not the first option. [My Copy] Nature reviews. Nephrology, Vol. 5, No. 7. (July 2009), pp. 367-368. by P. Ruggenenti, P. Cravedi, G. Remuzzi posted to acei arb proteinuria by guhjy on 2009-07-04 11:46:29 as
	Disruption of the Ang II type 1 receptor promotes longevity in mice. [My Copy] The Journal of clinical investigation, Vol. 119, No. 3. (March 2009), pp. 524-530. by Ariela Benigni, Daniela Corna, Carla Zoja, et al.Aurelio Sonzogni, Roberto Latini, Monica Salio, Sara Conti, Daniela Rottoli, Lorena Longaretti, Paola Cassis, Marina Morigi, Thomas M. Coffman, Giuseppe Remuzzi posted to aging at1 ko mouse by guhjy on 2009-06-29 05:02:52 as
	Thrice-weekly in-center nocturnal hemodialysis: an effective strategy to optimize chronic dialysis therapy. [My Copy] The International journal of artificial organs, Vol. 32, No. 1. (January 2009), pp. 12-19. by P. Cravedi, P. Ruggenenti, G. Mingardi, M. C. Sghirlanzoni, G. Remuzzi posted to bp hd nocturnal by guhjy on 2009-06-21 03:01:12 as
	Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition. [My Copy] The American journal of pathology, Vol. 174, No. 3. (March 2009), pp. 797-807. by D. Macconi, F. Sangalli, M. Bonomelli, et al.S. Conti, L. Condorelli, E. Gagliardini, G. Remuzzi, A. Remuzzi posted to acei podocyte by guhjy on 2009-04-26 05:02:24 as
	Thrombotic microangiopathy: What not to learn from a meta-analysis [My Copy] Nat Rev Nephrol, Vol. 5, No. 4. (April 2009), pp. 186-188. by Marina Noris, Giuseppe Remuzzi posted to hus meta-analysis by guhjy on 2009-04-26 04:22:33 as
	Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. [My Copy] The New England journal of medicine, Vol. 360, No. 14. (2 April 2009), pp. 1395-1407. by Bengt C. Fellström, Alan G. Jardine, Roland E. Schmieder, et al.Hallvard Holdaas, Kym Bannister, Jaap Beutler, Dong-Wan W. Chae, Alejandro Chevaile, Stuart M. Cobbe, Carola Grönhagen-Riska, José J. De Lima, Robert Lins, Gert Mayer, Alan W. McMahon, Hans-Henrik H. Parving, Giuseppe Remuzzi, Ola Samuelsson, Sandor Sonkodi, D. Sci, Gultekin Süleymanlar, Dimitrios Tsakiris, Vladimir Tesar, Vasil Todorov, Andrzej Wiecek, Rudolf P. Wüthrich, Mattis Gottlow, Eva Johnsson, Faiez Zannad, AURORA Study Group posted to statin rosuvastatin rct hd cv by guhjy on 2009-04-05 03:33:43 as along with 3 people djmonstermo omalbam Terkko
	Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. [My Copy] Lancet, Vol. 365, No. 9463. (8 2005), pp. 939-946. by P. Ruggenenti, A. Perna, G. Loriga, et al.M. Ganeva, B. Ene-Iordache, M. Turturro, M. Lesti, E. Perticucci, I. N. Chakarski, D. Leonardis, G. Garini, A. Sessa, C. Basile, M. Alpa, R. Scanziani, G. Sorba, C. Zoccali, G. Remuzzi, posted to renoprotection acei bp ccb ndrd rct by guhjy on 2009-03-22 04:07:05 as along with 1 person brainsman2000
	Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. [My Copy] Lancet, Vol. 354, No. 9176. (31 July 1999), pp. 359-364. by P. Ruggenenti, A. Perna, G. Gherardi, et al.G. Garini, C. Zoccali, M. Salvadori, F. Scolari, F. P. Schena, G. Remuzzi posted to renoprotection acei ndrd rct rein by guhjy on 2009-03-21 08:12:11 as
	Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus. [My Copy] Journal of hypertension, Vol. 25, No. 9. (September 2007), pp. 1921-1926. by N. K. Hollenberg, H. H. Parving, G. Viberti, et al.G. Remuzzi, S. Ritter, S. Zelenkofske, A. Kandra, W. L. Daley, R. Rocha posted to arb dm dose uae by guhjy on 2009-03-21 01:33:37 as
	Intensified inhibition of Renin-Angiotensin system: a way to improve renal protection? [My Copy] Current hypertension reports, Vol. 11, No. 2. (April 2009), pp. 118-124. by P. Cravedi, P. Ruggenenti, G. Remuzzi posted to acei arb dn dose by guhjy on 2009-03-15 09:53:38 as
	Screening for chronic kidney disease in emerging countries: feasibility and hurdles. [My Copy] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (13 February 2009) by Norberto Perico, Rodolfo Flores Bravo, Felipe Rodriguez De Leon, Giuseppe Remuzzi posted to ckd screening by guhjy on 2009-02-28 00:58:45 as
	Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. [My Copy] Cochrane database of systematic reviews (Online), No. 3. (2008) by Norbert Braun, Frank Schmutzler, Catalina Lange, et al.Annalisa Perna, Giuseppe Remuzzi, Teut Risler, Narelle S. Willis posted to meta-analysis fgs by guhjy on 2009-01-25 09:47:52 as
	Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. [My Copy] J Hypertens, Vol. 24, No. 2. (February 2006), pp. 403-408. by H. Haller, G. C. Viberti, A. Mimran, et al.G. Remuzzi, A. J. Rabelink, E. Ritz, L. C. Rump, L. M. Ruilope, S. Katayama, S. Ito, J. L. Izzo, A. Januszewicz posted to arb cv dn normoalbuminuria olmesartan primary-prevention rct uae by guhjy on 2009-01-21 14:55:03 as
	Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination. [My Copy] Vascular health and risk management, Vol. 3, No. 4. (2007), pp. 453-465. by S. K. Sharma, P. Ruggenenti, G. Remuzzi posted to acei bp ccb dm rct by guhjy on 2009-01-20 14:04:39 as
	Progression, remission, regression of chronic renal diseases. [My Copy] Lancet, Vol. 357, No. 9268. (19 May 2001), pp. 1601-1608. by P. Ruggenenti, A. Schieppati, G. Remuzzi posted to ckd-progression ckd meta-analysis proteinuria uae by guhjy on 2009-01-18 15:04:01 as
	Hepatitis C infection and chronic renal diseases. [My Copy] Clinical journal of the American Society of Nephrology : CJASN, Vol. 4, No. 1. (1 January 2009), pp. 207-220. by Norberto Perico, Dario Cattaneo, Boris Bikbov, Giuseppe Remuzzi posted to ckd hcv by guhjy on 2009-01-17 13:18:27 as
	ACE Inhibitors to Prevent End-Stage Renal Disease: When to Start and Why Possibly Never to Stop: A Post Hoc Analysis of the REIN Trial Results [My Copy] J Am Soc Nephrol, Vol. 12, No. 12. (1 December 2001), pp. 2832-2837. by Piero Ruggenenti, Annalisa Perna, Giuseppe Remuzzi posted to acei ckd rct rein by guhjy on 2009-01-13 04:39:45 as
	Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). [My Copy] Kidney international, Vol. 53, No. 5. (May 1998), pp. 1209-1216. by P. Ruggenenti, A. Perna, L. Mosconi, R. Pisoni, G. Remuzzi posted to ckd ndrd proteinuria rct rein by guhjy on 2009-01-03 03:35:30 as
	Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen) [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 11, No. 1. (January 2000), pp. 88-96. by P. Ruggenenti, A. Perna, C. Zoccali, et al.G. Gherardi, R. Benini, A. Testa, G. Remuzzi posted to ace acei ckd gender gn rct snp by guhjy on 2009-01-03 03:24:29 as
	Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 16 Suppl 1 (March 2005) by C. Chiurchiu, G. Remuzzi, P. Ruggenenti posted to ndrd acei ckd meta-analysis proteinuria rct by guhjy on 2009-01-03 03:23:31 as
	Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. [My Copy] Am J Kidney Dis, Vol. 35, No. 6. (June 2000), pp. 1155-1165. by P. Ruggenenti, A. Perna, G. Gherardi, R. Benini, G. Remuzzi posted to acei gn proteinuria rct rein by guhjy on 2009-01-03 03:20:50 as along with 1 person brainsman2000
	The future of renoprotection: Frustration and promises [My Copy] Kidney Int, Vol. 64, No. 6. (December 2003), pp. 1947-1955. by Arrigo Schieppati, Giuseppe Remuzzi posted to renoprotection by guhjy on 2009-01-01 12:19:04 as
	Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. [My Copy] Kidney Int, Vol. 65, No. 6. (June 2004), pp. 2309-2320. by D. de Zeeuw, G. Remuzzi, H. H. Parving, et al.W. F. Keane, Z. Zhang, S. Shahinfar, S. Snapinn, M. E. Cooper, W. E. Mitch, B. M. Brenner posted to renoprotection dn rct uae by guhjy on 2009-01-01 09:41:05 as
	Kidney injury molecule 1: in search of biomarkers of chronic tubulointerstitial damage and disease progression. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 53, No. 1. (January 2009), pp. 1-4. by N. Perico, D. Cattaneo, G. Remuzzi posted to biomarker ckd kim1 by guhjy on 2008-12-26 02:17:52 as
	Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. [My Copy] Circulation, Vol. 110, No. 8. (24 August 2004), pp. 921-927. by D. de Zeeuw, G. Remuzzi, H. H. Parving, et al.W. F. Keane, Z. Zhang, S. Shahinfar, S. Snapinn, M. E. Cooper, W. E. Mitch, B. M. Brenner posted to cv dm dn renaal uae by guhjy on 2008-12-16 02:01:50 as
	Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia. [My Copy] Kidney international. Supplement, No. 97. (August 2005) by N. Perico, R. Plata, A. Anabaya, et al.I. Codreanu, A. Schieppati, P. Ruggenenti, G. Remuzzi posted to ckd-progression ckd screening by guhjy on 2008-12-08 14:25:03 as
	Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) [My Copy] Diabetes Care, Vol. 31, No. 8. (1 August 2008), pp. 1629-1634. by Piero Ruggenenti, Ilian Iliev, Grazia M. Costa, et al.Aneliya Parvanova, Annalisa Perna, Giovanni A. Giuliano, Nicola Motterlini, Bogdan Ene-Iordache, Giuseppe Remuzzi, The posted to acei benedict dm lvh by guhjy on 2008-12-03 06:08:02 as
	Prevention programmes of progressive renal disease in developing nations (Review Article) [My Copy] Nephrology, Vol. 11, No. 4. (August 2006), pp. 321-328. by Igor Codreanu, Norberto Perico, Sanjib K. Sharma, Arrigo Schieppati, Giuseppe Remuzzi posted to asia ckd by guhjy on 2008-12-01 05:04:25 as
	New strategies to prevent cardiovascular risk in chronic kidney disease. [My Copy] Kidney international, Vol. 74, No. S111. (December 2008) by José Luño, Giuseppe Remuzzi, Bernardo Rodriguez-Iturbe, Juan C C. Ayus posted to ckd cv by guhjy on 2008-11-28 02:20:27 as
	Treating the kidney to cure the heart. [My Copy] Kidney international. Supplement, Vol. 74, No. 111. (December 2008) by Paolo Cravedi, Giuseppe Remuzzi posted to cardiorenal arb acei by guhjy on 2008-11-28 02:14:27 as
	Preventing microalbuminuria in type 2 diabetes. [My Copy] The New England journal of medicine, Vol. 351, No. 19. (4 November 2004), pp. 1941-1951. by Piero Ruggenenti, Anna Fassi, Anelja Parvanova P. Ilieva, et al.Simona Bruno, Ilian Petrov P. Iliev, Varusca Brusegan, Nadia Rubis, Giulia Gherardi, Federica Arnoldi, Maria Ganeva, Bogdan Ene-Iordache, Flavio Gaspari, Annalisa Perna, Antonio Bossi, Roberto Trevisan, Alessandro R. Dodesini, Giuseppe Remuzzi, Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators posted to uae rct normoalbuminuria dm benedict by guhjy on 2008-11-26 07:33:25 as
	Targeted Deletion of Angiotensin II Type 1A Receptor Does not Protect Mice from Progressive Nephropathy of Overload Proteinuria [My Copy] J Am Soc Nephrol, Vol. 15, No. 10. (1 October 2004), pp. 2666-2674. by Ariela Benigni, Daniela Corna, Carla Zoja, et al.Lorena Longaretti, Elena Gagliardini, Norberto Perico, Thomas M. Coffman, Giuseppe Remuzzi posted to at1 ko mouse proteinuria by guhjy on 2008-11-09 15:05:14 as
	Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. [My Copy] Kidney international, Vol. 60, No. 3. (September 2001), pp. 1131-1140. by T. H. Jafar, P. C. Stark, C. H. Schmid, et al.M. Landa, G. Maschio, C. Marcantoni, P. E. de Jong, D. de Zeeuw, S. Shahinfar, P. Ruggenenti, G. Remuzzi, A. S. Levey, posted to acei ckd ndrd proteinuria rct by guhjy on 2008-10-22 09:43:18 as
	Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. [My Copy] Annals of internal medicine, Vol. 135, No. 2. (17 July 2001), pp. 73-87. by T. H. Jafar, C. H. Schmid, M. Landa, et al.I. Giatras, R. Toto, G. Remuzzi, G. Maschio, B. M. Brenner, A. Kamper, P. Zucchelli, G. Becker, A. Himmelmann, K. Bannister, P. Landais, S. Shahinfar, P. E. de Jong, D. de Zeeuw, J. Lau, A. S. Levey posted to ndrd acei ckd meta-analysis proteinuria by guhjy on 2008-10-22 09:42:09 as
	The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. [My Copy] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 18, No. 10. (October 2003), pp. 2047-2053. by Tazeen H. Jafar, Christopher H. Schmid, Paul C. Stark, et al.Robert Toto, Giuseppe Remuzzi, Piero Ruggenenti, Carmelita Marcantoni, Gavin Becker, Shahnaz Shahinfar, Paul E. De Jong, Dick De Zeeuw, Anne-Lise L. Kamper, Svend Strangaard, Andrew S. Levey posted to ckd-progression ckd gender by guhjy on 2008-10-22 09:35:15 as
	Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection [My Copy] Nature Reviews Drug Discovery, Vol. 7, No. 11. (10 October 2008), pp. 936-953. by Norberto Perico, Ariela Benigni, Giuseppe Remuzzi posted to renoprotection treatment ckd by guhjy on 2008-10-22 02:49:20 as
	Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. [My Copy] BMJ (Clinical research ed.), Vol. 316, No. 7130. (14 February 1998), pp. 504-509. by P. Ruggenenti, F. Gaspari, A. Perna, G. Remuzzi posted to urine esrd longitudinal outcome proteinuria spot-urine by guhjy on 2008-07-15 11:10:13 as
	Angiotensin Converting Enzyme Insertion/Deletion Polymorphism and Renoprotection in Diabetic and Nondiabetic Nephropathies. [My Copy] Clinical journal of the American Society of Nephrology : CJASN (11 June 2008) by Piero Ruggenenti, Paola Bettinaglio, Franck Pinares, Giuseppe Remuzzi posted to renoprotection ace ckd dn snp by guhjy on 2008-07-14 11:22:55 as

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/author/Remuzzi:G

Result page: 1 2 Next

ckd	1732
rct	1192
dn	1067
dm	994
ma	969
cancer	959
cv	898
hd	856
tgfb	787
snp	760
bp	632
ros	559
meta-analysis	516
uae	496
stats	476
kidney	463
software	458
mouse	451
genetics	443
mirna	441
pt	410
proteomics	409
mortality	408
inflammation	363
fbl	356
proteinuria	353
rat	352
pcr	348
tw	345
db	326
acei	325
gdl	325
test	325
urine	315
inhibitor	312
arb	308
ms	306
method	303
hcv	299
age	297
apoptosis	297
r	291
mc	290
aging	285
biomarker	285
irs	277
ppi	274
bayes	273
bias	272
gwa	266
akt	264
aki	262
nutrition	255
hg	253
aii	245
rnai	242
emt	240
mtor	232
fibrosis	230
p53	227
cox	226
egfr	225
ub	222
pbmc	220
smad	219
obesity	218
drug	211
metab	211
hcc	210
gn	208
hypoxia	204
pi3k	203
herb	196
albumin	189
lc	185
collagen	179
erk	179
longitudinal	179
lmm	178
gfr	176
hif	176
stz	173
nfkb	172
ua	170
pubmed	169
epigenetics	168
japan	165
1	161
gender	161
p38	161
cea	160
lead	159
power	159
rage	159
cadmium	156
dna-damage	156
bioinf	155
ref	154
genomics	148
stata	147
vitamin-d	146
ctgf	144
network	142
screening	137
liver	134
rt	134
diet	131
seq	131
company	129
protein	129
phosphorylation	127
go	125
systems-biology	124
pathway	122
cell-cycle	120
no	120
mt	118
book	117
esrd	117
lipid	117
creatinine	115
kinase	113
pkc	113
statin	112
podocyte	105
senescence	104
fish	103
proliferation	103
regression	103
case-control	102
gfr-formula	102
pd	102
imputation	101
mapk	101
cad	100
imaging	99
rx	98
plasmid	97
cloning	96
multiplicity	96
methylation	95
observational	95
pediatric	95
recurrent	94
p21	93
blood	91
betel	90
nhanes	90
nox	90
sirt	90
tnf	90
website	89
chf	88
phenotype	88
pparg	88
toxicology	88
cytokine	87
diagnosis	87
anemia	86
insulin	86
immunity	85
uti	85
lr	84
china	83
src	83
epo	82
stat	82
nonp	81
oat	81
p	81
cachexia	80
hapmap	80
hypertrophy	80
at1	79
ebm	79
environment	79
gout	78
primer	78
review	76
qms	74
s6k	74
missing	73
promoter	73
eqtl	72
gene-list	72
gene-therapy	72
ko	72
lpd	72
surrogate	72
ace	71
mv	71
salt	70
egf	69
phd	69
stone	69
autophagy	68
signaling	68
cox2	67
mgo	66
uncertainty	66
mirna-target	65
normalization	65
tin	65
association	64
causation	63
chinese	63
foxo	63
glycemia	63
yeast	63
2dge	62
acid-base	62
enddysf	62
me	62
simulation	62
confounding	61
hts	61
jnk	61
pla2	61
smoking	61
avf	60
gpcr	60
melamine	60
outcome	60
pe	60
sas	60
uuo	60
cost	59
infection	59
oral	59
shc	59
alcohol	58
change	58
crp	58
mmp	58
ptm	58
achr	57
llcpk1	57
nrk49f	57
pai1	57
pls	57
robust	57
urate-transporter	57
aceiarb	56
calibration	56
fluorescence	56
hk2	56
hsp	56
model-selection	56
pdgf	56
semantic	56
competing-risk	55
goldstd	55
ifn	55
oglcnac	55
ratio	55
bone	54
estrogen	54
function	54
iron	54
p-value	54
workflow	54
ckd-progression	53
dipstick	53
k	53
std	53
ace2	52
histone	52
qc	52
renoprotection	52
stem-cell	52
atm	51
epidemiology	51
fgf	51
lod	51
ncrna	51
normoalbuminuria	51
pth	51
arsenic	50
dimerization	50
matlab	50
mercury	50
reasoning	50
rho	50
risk-ratio	50
ab	49
antibiotics	49
cyclin-d1	49
epistasis	49
gene-environment	49
graph	49
hsc	49
adpkd	48
breakpoint	48
core-curriculum	48
klotho	48
nrk52e	48
pld	48
tf	48
ukm	48
ffpe	47
joint-model	47
mesangial	47
ngal	47
pooling	47
protein-microarray	47
spot-urine	47
vegf	47
aspirin	46
cystatin	46
ecm	46
fdr	46
hdac	46
hgf	46
il6	46
biosensor	45
endothelium	45
fgf23	45
metal	45
p27	45
prevention	45
rapamycin	45
ras	45
semip	45
writing	45
aldosterone	44
ancova	44
ca	44
variability	44
wnt	44
bia	43
cnv	43
design	43
enos	43
interaction	43
klf	43
na	43
sle	43
agreement	42
bmi	42
ccb	42
dub	42
good	42
icu	42
roc	42
sumo	42
diuretics	41
er-stress	41
igf	41
stroke	41
tgfbr	41
alignment	40
dbdb	40
fuzzy	40
gene-targeting	40
risk	40
wga	40
dry-bw	39
hepatocyte	39
hyperfiltration	39
qtl	39
ap1	38
asia	38
protein-complex	38
rsk	38
sage	38
urinalysis	38
adh	37
animal	37
antisense	37
bh4	37
fabp	37
haplotype	37
hematuria	37
igan	37
translation	37
adenosine	36
angiogenesis	36
cardiorenal	36
catenin	36
emr	36
inflammasome	36
omics	36
propensity	36
tea	36
tlr	36
web20	36
adduct	35
ampk	35
annotation	35
candidate-gene	35
chemogenomics	35
cre	35
gsk	35
megalin	35
myc	35
s100b	35
subgroup	35
attrition	34
calcium	34
cross-species	34
msm	34
pathology	34
proteasome	34
reverse-epidemiology	34
sepsis	34
threshold	34
cage	33
calcification	33
coffee	33
exercise	33
fibronectin	33
mtorc1	33
nephrotoxicity	33
ns	33
rca	33
sarcopenia	33
snx	33
sp1	33
zeb	33
addgene	32
affy	32
browser	32
end-point	32
il1	32
text-mining	32
zfn	32
blast	31
ecology	31
effect-size	31
emsa	31
family	31
fc	31
frailty	31
gllamm	31
heritability	31
hospitalization	31
macrophage	31
orbitrap	31
risk-difference	31
set	31
steroid	31
transactivation	31
abp	30
bmp	30
creb	30
knockout	30
membrane-protein	30
mw	30
notch	30
staging	30
transporter	30
3	29
ai	29
et	29
extraction	29
grn	29
nicotinic	29
nutrient	29
reporter	29
s100	29
validation	29
vsmc	29
acetylation	28
gee	28
geo	28
integrin	28
mutagenesis	28
perindopril	28
pka	28
race	28
rtk	28
rvh	28
scaling	28
time-dependent	28
carcinogen	27
cari	27
ce	27
ck2	27
classification	27
human	27
mendelian	27
ndrd	27
pdz	27
spla2	27
gsh	26
hba1c	26
hplc	26
hyaluronan	26
metagenomics	26
silac	26
thp	26
ub-ligase	26
biomonitor	25
censor	25
indirect	25
jun	25
matching	25
mg	25
mtorc2	25

guhjy's Remuzzi:G [78 articles] Export

guhjy's tags